SARS-CoV-2 has a variety of accessory proteins that help it evade and suppress our immune system. Recent findings suggest that the accessory protein ORF7a helps suppress our immune cells, making it harder for the virus to be detected.
Subscribe to:
Post Comments (Atom)
< + > Clinical Trials with Denali Rose – Life Sciences Today Podcast Episode 44
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Denali Rose, VP a...
-
As I’m sure you know, times are tough. Wages have largely remained the same while prices have risen across the board – and healthcare is no ...
-
Solution Erases Long Phone Holds for Patients, Supports Overwhelmed Medical Front Desk Workers, and Improves Patient Access to Physicians A...
-
Announcement written by Zack Kanter, Founder and CEO at Stedi In February of last year, I gathered our engineering team in a war room. Chan...
No comments:
Post a Comment